1
|
Authier D, Hegenbart U, Pohl F, Rosenwald A, Kircher S, Menhart K, Perl M, Cerny J, Mayer S, Herr W, Grube M. Low dose stereotactic irradiation and dexamethasone in primary cerebral light chain deposition disease (LCDD). Leuk Lymphoma 2021; 62:2267-2271. [PMID: 33787427 DOI: 10.1080/10428194.2021.1907380] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Daniel Authier
- Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
| | - Ute Hegenbart
- Amyloidosis Center, University Hospital Heidelberg, Heidelberg, Germany
| | - Fabian Pohl
- Department of Radiotherapy, University Hospital Regensburg, Regensburg, Germany
| | | | - Stefan Kircher
- Institute of Pathology, University Würzburg, Würzburg, Germany
| | - Karin Menhart
- Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany
| | - Markus Perl
- Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
| | - Jindrich Cerny
- Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
| | - Stephanie Mayer
- Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
| | - Wolfgang Herr
- Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
| | - Matthias Grube
- Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
| |
Collapse
|